Abstracts-highlighting

MEI Pharma Reports Third Quarter Fiscal Year 2022 Results and Operational Highlights

MEI Begins Fourth Fiscal Quarter with $169.0 Million in Cash-- MEI Pharma, Inc. (Nasdaq: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer ... read more

MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress

MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, and Kyowa Kirin Co., Ltd. (Kyowa Kirin, TSE: 4151), a global specialty ... read more

The power of ‘seeing what you treat’ with Elekta Unity reported in 71 abstracts at ESTRO 2022

STOCKHOLM – Elekta (EKTA-B.ST) today announced that Elekta Unity clinical users worldwide presented 71 new abstracts highlighting the high-field magnetic resonance radiation therapy (MR/RT) system’s ... read more

Iterative Scopes to Present Three Abstracts on Artificial Intelligence Applications for GI Endoscopy at DDW 2022

The plenary sessions at DDW are the forum for highlighting some of the year’s best research abstracts as determined by the conference organizers. In her discussion, Dr. Shaukat will highlight results ... read more

Iterative Scopes to Present Three Abstracts on Artificial Intelligence Applications for GI Endoscopy at DDW 2022

The plenary sessions at DDW are the forum for highlighting some of the year's best research abstracts as determined by the conference organizers. In her discussion, Dr. Shaukat will highlight ... read more

Apellis Announces Seven Abstracts In PNH To Be Presented At The European Hematology Association Congress

May 12, 2022 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical company and leader in complement, today announced that seven abstracts will be presented ... read more

MEI Pharma and Kyowa Kirin Announce Acceptance of Two Abstracts for Presentation at the European Hematology Association 2022 Hybrid Congress

today announced that two abstracts highlighting data and information for zandelisib, an investigational phosphatidylinositol 3-kinase delta ("PI3K?") inhibitor in clinical development for the ... read more

Astellas Highlights Data on Advanced and Rare Cancers during 2022 ASCO Annual Meeting and EHA 2022 Hybrid Congress

Abstracts represent exciting research progress across four cancers where patients have limited treatment options ... read more

Related Blogs:

Abstracts Highlighting Research Announced Company Nasdaq Today Announced





Real Time RSS Feeds | Disclaimer | Contact Us